Heated intraperitoneal chemotherapy (HIPEC) use for ovarian cancer in the United States increases after publication of clinical trial and is associated with higher short-term cost and morbidity
| Autor: | Charo, L.M., Jou, J., Binder, P.S., Saenz, C.C., McHale, M.T., Eskander, R.N., Plaxe, S.C. |
|---|---|
| Zdroj: | In Gynecologic Oncology October 2020 159 Supplement 1:53-54 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect